Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system

Ali, Zahid, Ismail, Mohammad, Khan, Fahadullah, Sajid, Hira · 2021 · Expert Opinion on Drug Safety

Abstract

Background: This study aimed to measure the association of various H1-antihistamines (H1A) with Torsade de Pointes (TdP), and present a comprehensive overview of H1A-induced TdP cases reported to the Food and Drug Administration Adverse Event Reporting System (FAERS).Methods: All H1A-induced TdP cases (n = 406) were retrieved from the FAERS database using the preferred term ‘Torsade de Pointes’ of MedDRA version-22 from 1990 to 2019. Four data-mining algorithms were used for disproportionality analysis: Reporting Odds Ratio (ROR); Proportional Reporting Ratio (PRR), Empirical Bayes Geometric Mean (EBGM), and Information Content (IC). H1A with >3 TdP cases were included.Results: A total of 12 signals (Astemizole, cetirizine, chlorpheniramine, clemastine, desloratadine, diphenhydramine, hydroxyzine, loratadine, meclizine, promethazine, terfenadine, and trimeprazine) were identified including six new signals (cetirizine, chlorpheniramine, clemastine, desloratadine, loratadine, and meclizine). The number of risk factors (p = 0.031) and concomitant QT-prolonging drugs (p = <0.001) were significantly lower among new signals vs old signals. Moreover, new signals were strongly associated with QT-prolongation, cardiac reactions, and electrolyte abnormalities as compared with old signals.Conclusions: Our study found the increased torsadogenic potential of new signals compared with previously known old signals, hence necessitating clinical studies to determine the actual torsadogenic potential of newly identified signals.

Overview

Integrity signals

Registry

Crossref · 10.1080/14740338.2021.1846717

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 7

  1. Li M, 2017, P T, 42, 473
  2. Martínez L, 2018, J Anal Pharm Res, 7, 197
  3. Kuo CC, 2000, Mol Pharmacol, 57, 135
  4. Martin LL, 2017, S D Med, 70, 135
  5. 2010, Prescrire Int, 19, 26
  6. Renard S, 2005, Arch Mal Coeur Vaiss, 98, 157
  7. 10.4196/kjpp.2009.13.3.215 · DOI

Cited by

See all 21

Metadata

Authors
Ali, Z., Ismail, M., Khan, F., & Sajid, H.
Affiliations
University of Peshawar (PK)
Corresponding author
Ismail, Mohammad
Venue
Expert Opinion on Drug Safety
Published
2020-11-13
Volume
20
Issue
1
Pages
101-108
ISSN
  • 1474-0338 (ISSN-L)
  • 1744-764X
OpenAlex
W3095571268
Cited by
21
References
28
Citations by year
2026: 5 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 1
FWCI
1.24
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
Funders
did not receive
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
histamine H1 receptor antagonists, torsades de pointes, drug-induced arrhythmia, QT prolongation, adverse drug reactions, disproportionality analysis, FDA Adverse Event Reporting System, drug safety signals, antihistamines, terfenadine, astemizole, diphenhydramine, loratadine, meclizine, clemastine, chlorpheniramine, desloratadine, citalopram
MeSH terms
Adolescent, Adult, Aged, Algorithms, Child, Child, Preschool, Female, Histamine H1 Antagonists, Humans, Infant, Long QT Syndrome, Male, Middle Aged, Risk Factors, United States, United States Food and Drug Administration, Torsades de Pointes, Databases, Factual, Adverse Drug Reaction Reporting Systems, Young Adult, Data Mining, Pharmacovigilance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system. https://app.cochat.ai/papers/10.1080/14740338.2021.1846717
The paper
Ali, Z., Ismail, M., Khan, F., & Sajid, H. (2021). Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2021.1846717

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.